Detection of tyrosinase autoantibodies in patients with vitiligo using S-35-labeled recombinant human tyrosinase in a radioimmunoassay

Tyrosinase antibodies recently have been reported to occur frequently in patients with vitiligo, We describe the detection of tyrosinase antibodies in vitiligo patients using in vitro S-35-labeled human tyrosinase in a radioimmunoassay. Of 46 vitiligo sera examined in the assay, five (10.9%) were found to be positive for tyrosinase antibodies, In contrast, 20 control sera and sera from 10 patients with Mashimoto's thyroiditis were negative, Four of the sera positive in the radioimmunoassay were also positive in an ELISA using mushroom tyrosinase as antigen. Absorption studies indicated that pre-incubation with mushroom tyrosinase absorbed out the immunoreactivity of the positive sera in the radioimmunoassay, suggesting cross-reactivity, but this absorption was never complete, indicating that there are tyrosinase antibodies in human sera that do not react with the mushroom protein. There was no obvious association between the presence of tyrosinase antibodies and the age of the patients (range: 22-62 y), their duration of disease (range: 5-20 y), or the type of vitiligo (one segmental, one symmetrical/periorificial, three symmetrical), although the three patients with the highest antibody levels also had an associated autoimmune disorder (one with Graves' disease; two with autoimmune hypothyroidism). The results confirm that tyrosinase autoantibodies are present in the sera of vitiligo patients but at a low frequency. The technique described is sensitive and quantitative and allows the detection of conformational epitopes, It will be useful in longitudinal studies to determine the relation between the clinical features of vitiligo and tyrosinase antibody levels.